We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
+14.93%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$73.9B
AUM Growth
+$5.6B
(+8.2%)
Cap. Flow
-$3.28B
Cap. Flow
% of AUM
-4.43%
Top 10 Holdings %
Top 10 Hldgs %
14.52%
Holding
790
New
69
Increased
319
Reduced
276
Closed
94
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$274M |
| 2 |
Advanced Micro Devices
AMD
|
+$193M |
| 3 |
Booking.com
BKNG
|
+$166M |
| 4 |
Prologis
PLD
|
+$153M |
| 5 |
Valvoline
VVV
|
+$115M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$683M |
| 2 |
Meta Platforms (Facebook)
META
|
+$428M |
| 3 |
SLB Ltd
SLB
|
+$322M |
| 4 |
Dominion Energy
D
|
+$239M |
| 5 |
AutoZone
AZO
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.4% |
| 2 | Healthcare | 17.66% |
| 3 | Industrials | 15.23% |
| 4 | Technology | 13.58% |
| 5 | Consumer Discretionary | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Herbalife
HLF
$1.26B
| $26M | 0.04% |
+1,675,430
| New | +$29.2M |
|
277
PRA Group
PRAA
$713M
| $26M | 0.04% |
745,053
+18,912
| +3% | +$623K |
|
278
NCR Voyix
VYX
$1.09B
| $25.7M | 0.03% |
1,732,584
-18,810
| -1% | -$250K |
|
|
VSXY
279
Victoria's Secret
VSXY
$5.88B
| $25.6M | 0.03% |
682,375
+17,620
| +3% | +$700K |
|
280
Cactus
WHD
$4.76B
| $25.1M | 0.03% |
493,838
+178,650
| +57% | +$8.96M |
|
281
Hancock Whitney
HWC
$6.13B
| $24.9M | 0.03% |
508,198
+492,650
| +3,169% | +$25.5M |
|
282
SouthState Bank Corp
SSB
$10.4B
| $24.5M | 0.03% |
317,905
+73,317
| +30% | +$6.15M |
|
283
iShares Russell 1000 Value ETF
IWD
$82.7B
| $24M | 0.03% |
152,434
+61,808
| +68% | +$9.25M |
|
284
AMN Healthcare
AMN
$1.32B
| $23.8M | 0.03% |
232,592
+66,970
| +40% | +$7.71M |
|
|
PENG
285
Penguin Solutions Inc
PENG
$2.43B
| $23.5M | 0.03% |
1,539,803
-59,985
| -4% | -$917K |
|
|
PDCE
286
DELISTED
PDC Energy, Inc.
PDCE
| $23.5M | 0.03% |
368,198
-347,333
| -49% | -$24.2M |
|
287
Ovintiv
OVV
$18.4B
| $23M | 0.03% |
334,935
+19,217
| +6% | +$1M |
|
288
Universal Health Services
UHS
$10.2B
| $22.4M | 0.03% |
158,905
+18,209
| +13% | +$2.15M |
|
289
Terex
TEX
$6.66B
| $21.9M | 0.03% |
500,051
-3,240
| -0.6% | -$130K |
|
290
ManpowerGroup
MAN
$2.67B
| $21.9M | 0.03% |
262,967
-16,966
| -6% | -$1.36M |
|
291
Highwoods Properties
HIW
$3.37B
| $21.8M | 0.03% |
+768,753
| New | +$21.4M |
|
|
VGR
292
DELISTED
Vector Group Ltd.
VGR
| $21.8M | 0.03% |
1,803,073
+1,698,986
| +1,632% | +$17.9M |
|
293
Nelnet
NNI
$4.56B
| $21.7M | 0.03% |
236,392
+28,252
| +14% | +$2.56M |
|
294
Par Pacific Holdings
PARR
$4.19B
| $21.7M | 0.03% |
914,625
-35,128
| -4% | -$765K |
|
295
Bloomin' Brands
BLMN
$721M
| $21.6M | 0.03% |
+1,043,848
| New | +$22.6M |
|
296
TTEC Holdings
TTEC
$61.6M
| $21.5M | 0.03% |
469,522
+671
| +0.1% | +$30.1K |
|
297
First Hawaiian
FHB
$3.16B
| $21.3M | 0.03% |
812,946
-395,686
| -33% | -$10.2M |
|
298
Acuity Brands
AYI
$9.06B
| $20.9M | 0.03% |
123,846
+119,138
| +2,531% | +$21.2M |
|
299
DNOW Inc
DNOW
$2.85B
| $20.7M | 0.03% |
1,611,014
+864,848
| +116% | +$10.5M |
|
300
Magna International
MGA
$17B
| $20.6M | 0.03% |
366,075
-23,677
| -6% | -$1.33M |
|
Similar funds
Boston Partners's Q4 2022 Portfolio in Review
As of Q4 2022, Boston Partners held 790 positions worth $73.9B, up 8.2% from $68.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Boston Partners withdrew a net $3.28B in Q4 2022, closing 94 positions and reducing 276 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $428M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Boston Partners opened a new position in Prologis worth $156M.
- Boston Partners's largest Q4 2022 buy was Prologis: 1,379,952 shares worth $156M.
- Boston Partners added most to Bristol-Myers Squibb in Q4 2022, an estimated $274M increase.
- Boston Partners's biggest Q4 2022 reduction was ConocoPhillips, cutting an estimated $683M.
- Boston Partners fully exited Meta Platforms (Facebook) in Q4 2022, selling an estimated $428M.
- Boston Partners's ten largest holdings make up 15% of its $73.9B portfolio in Q4 2022.
- Boston Partners opened 69 new positions and closed 94 in Q4 2022.
- Boston Partners's portfolio value rose 8.2% quarter-over-quarter to $73.9B.
Based on Boston Partners's 13F filing for Q4 2022, filed 8 Feb 2023.